Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s share price fell 2.7% during mid-day trading on Tuesday . The stock traded as low as $2.14 and last traded at $2.14. 3,930 shares were traded during mid-day trading, a decline of 100% from the average session volume of 842,200 shares. The stock had previously closed at $2.20.
Ampliphi Biosciences Stock Up 0.5 %
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Featured Articles
- Five stocks we like better than Ampliphi Biosciences
- What Are the U.K. Market Holidays? How to Invest and Trade
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- How to Use the MarketBeat Stock Screener
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- How to Calculate Options Profits
- BlackRock Makes Waves With $12B Private Credit Acquisition
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
